DEXTROSE 25% Drug Patent Profile
✉ Email this page to a colleague
When do Dextrose 25% patents expire, and what generic alternatives are available?
Dextrose 25% is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in DEXTROSE 25% is dextrose. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dextrose profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXTROSE 25%?
- What are the global sales for DEXTROSE 25%?
- What is Average Wholesale Price for DEXTROSE 25%?
Summary for DEXTROSE 25%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 16 |
| DailyMed Link: | DEXTROSE 25% at DailyMed |
US Patents and Regulatory Information for DEXTROSE 25%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | DEXTROSE 25% | dextrose | INJECTABLE;INJECTION | 019445-002 | Nov 23, 1998 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
